Literature DB >> 12537310

The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit.

Jean-Pierre Guignard1.   

Abstract

Nonsteroidal anti-inflammatory drugs are frequently used during pregnancy (premature labor, polyhydramnios) and the immediate postnatal period (closure of patent ductus arteriosus). This article evaluates the renal effect of 3 nonspecific COX inhibitors (aspirin, indomethacin, and ibuprofen) in newborn rabbits. Five groups of anesthetized, ventilated, normoxemic 6-day-old rabbits (n = 52) were administered intravenous aspirin (40 mg/kg), indomethacin (2 mg/kg), and ibuprofen (0.02, 0.2, 2.0 mg/kg, respectively). Renal function and hemodynamics as assessed by inulin and para-aminohippuric acid clearances were measured before and in the hour after drug administration. In all groups of animals, the nonselective COX inhibitors induced an increase in renal vascular resistance and a consequent decrease in glomerular filtration rate and renal blood flow. Urine flow rate decreased significantly in all groups, except in the group receiving the lowest dose of ibuprofen. In newborn rabbits, aspirin, indomethacin, and ibuprofen induced intense renal vasoconstriction, which resulted in impaired renal function. This observation illustrates the major renal protective role played by the vasodilatory prostaglandins during the neonatal period, when the kidney is perfused at very low perfusion pressure. We conclude that all COX inhibitors should be administered with the same caution to the preterm neonate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537310     DOI: 10.1053/sper.2002.37310

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  11 in total

1.  The impact of ibuprofen on renal clearance in preterm infants is independent of the gestational age.

Authors:  Karel Allegaert; Veerle Cossey; Anne Debeer; Jean Paul Langhendries; Bart Van Overmeire; Jan de Hoon; Hugo Devlieger
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

2.  Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus.

Authors:  Vincenzo Zanardo; Stefania Vedovato; Paola Lago; Daniele Trevisanuto; Flaviano Favaro; Diego Faggian; Mario Plebani
Journal:  Pediatr Nephrol       Date:  2005-08-17       Impact factor: 3.714

3.  Limited predictability of amikacin clearance in extreme premature neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Mapping vascular and glomerular pathology in a rabbit model of neonatal acute kidney injury using MRI.

Authors:  Neda Parvin; Jennifer R Charlton; Edwin J Baldelomar; Jamal J Derakhshan; Kevin M Bennett
Journal:  Anat Rec (Hoboken)       Date:  2020-06-07       Impact factor: 2.064

5.  Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates.

Authors:  Karel Allegaert; Christine Vanhole; Jan de Hoon; Jean Pierre Guignard; Dick Tibboel; Hugo Devlieger; Bart Van Overmeire
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

6.  The renal adverse effects of ibuprofen are not mediated by AQP2 water channels.

Authors:  Rachel Vieux; Marina Zelenina; Anita Aperia; Jean-Michel Hascoët
Journal:  Pediatr Nephrol       Date:  2010-07       Impact factor: 3.714

7.  A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children.

Authors:  Laura R Ment; Bradley S Peterson; Jed A Meltzer; Betty Vohr; Walter Allan; Karol H Katz; Cheryl Lacadie; Karen C Schneider; Charles C Duncan; Robert W Makuch; R Todd Constable
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

8.  Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus.

Authors:  R Antonucci; L Cuzzolin; A Arceri; A Dessì; V Fanos
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

Review 9.  Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

Review 10.  Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates.

Authors:  Karel Allegaert; Jan De Hoon; Anne Debeer; Marc Gewillig
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.